beta
AVXS
AveXis Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
AveXis Inc is a clinical-stage gene therapy company. It is engaged in developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its product candidate is AVXS-101.
Market Cap: 3.48 Billion
Primary Exchange: Nasdaq Global Select
Website: http://www.avexis.com
Shares Outstanding: 32 Million
Float: 29.9 Million
Dividend: 0.0 (0.0%)
Beta: 1.308978
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 88 trading days
From: 2016-06-02 To: 2016-10-06
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|